Waterloo Capital’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$697K Buy
10,404
+25
+0.2% +$1.56K 0.04% 291
2026
Q1
$640K Buy
10,379
+31
+0.3% +$2K 0.04% 267
2025
Q4
$674K Sell
10,348
-154
-1% -$9.72K 0.05% 255
2025
Q3
$617K Sell
10,502
-625
-6% -$35.6K 0.05% 241
2025
Q2
$628K Buy
11,127
+31
+0.3% +$1.75K 0.05% 236
2025
Q1
$676K Buy
11,096
+28
+0.3% +$1.71K 0.06% 211
2024
Q4
$645K Buy
11,068
+38
+0.3% +$2.35K 0.07% 201
2024
Q3
$717K Buy
11,030
+39
+0.4% +$2.49K 0.08% 195
2024
Q2
$673K Buy
10,991
+23
+0.2% +$1.38K 0.08% 185
2024
Q1
$679K Buy
10,968
+28
+0.3% +$1.68K 0.09% 188
2023
Q4
$626K Sell
10,940
-120
-1% -$6.53K 0.1% 181
2023
Q3
$597K Sell
11,060
-5
-0% -$279 0.18% 91
2023
Q2
$620K Sell
11,065
-2,260
-17% -$126K 0.18% 77
2023
Q1
$728K Buy
+13,325
New +$731K 0.23% 69

Other funds holding IYH

Waterloo Capital's IYH Position: Q2 2026 in Review

Waterloo Capital increased its iShares US Healthcare ETF (IYH) stake by 0.24% in Q2 2026, buying an estimated $1.56K and bringing the position to 10,404 shares worth $697K. The position accounts for 0.04% of the portfolio, ranked #291.

Waterloo Capital first reported a position in IYH in Q1 2023 and has held it in 14 quarters since. The position peaked at $728K in Q1 2023. 534 funds tracked by Wall St. Rank hold IYH as of Q2 2026.

  • Waterloo Capital held 10,404 shares of iShares US Healthcare ETF worth $697K as of Q2 2026.
  • Waterloo Capital bought 25 iShares US Healthcare ETF shares in Q2 2026, an estimated $1.56K.
  • iShares US Healthcare ETF made up 0.04% of Waterloo Capital's portfolio in Q2 2026, its #291 holding.
  • Waterloo Capital first reported a position in iShares US Healthcare ETF in Q1 2023 and has held it in 14 quarters since.
  • Waterloo Capital's iShares US Healthcare ETF position peaked at $728K in Q1 2023.
  • 534 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.